Structural Targeting of Potentially Protective gp120 Epitopes in the C1/C2 Region

Medicine & Life Sciences

1. Epitopes 100%
2. Fc Receptors 93%
3. Antibodies 64%
4. Vaccines 58%
5. HIV-1 22%
6. AIDS Vaccines 16%
7. Proof of Concept Study 16%
8. Financial Management 14%
9. HIV Infections 11%
10. Hand 9%
11. HIV 8%
12. Viruses 8%
13. Animals 6%
14. Infections 6%